Cambridge Stem Cell Institute.

Thirty research teams studying stem cells will move into a single 8,000-square-metre building on the Cambridge Biomedical Research Campus, creating a dedicated centre for both fundamental biology and medical translation. Stem cells can renew themselves and turn into many different cell types, but how these processes work at the molecular level—and how they go wrong in diseases such as cancer—remains incompletely understood. The Cambridge Stem Cell Institute will bring together scientists working on self-renewal, differentiation, and reprogramming, alongside clinicians testing cell-based therapies. This co-location is designed to accelerate progress by making it easier for researchers to share tools, data, and ideas. If the institute succeeds, it could speed the development of treatments that use a patient’s own reprogrammed cells to model disease, screen drugs, or repair damaged tissue. It may also lead to strategies that coax the body’s own stem cells into regenerating organs after injury or ageing. Much of the work is fundamental science—investigating the basic rules of how cells decide their fate—but similar curiosity-driven research into stem cells has already produced clinical trials for conditions such as Parkinson’s disease and macular degeneration. The institute will also train the next generation of stem cell biologists and partner with the biotech industry to move discoveries from the lab into the clinic.